NSE - Delayed Quote INR

Archean Chemical Industries Limited (ACI.NS)

Compare
546.90
+8.60
+(1.60%)
At close: 3:30:01 PM GMT+5:30
Loading Chart for ACI.NS
  • Previous Close 538.30
  • Open 529.00
  • Bid --
  • Ask --
  • Day's Range 526.75 - 555.90
  • 52 Week Range 408.35 - 832.00
  • Volume 262,030
  • Avg. Volume 680,408
  • Market Cap (intraday) 67.503B
  • Beta (5Y Monthly) 0.42
  • PE Ratio (TTM) 40.63
  • EPS (TTM) 13.46
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield 5.50 (1.02%)
  • Ex-Dividend Date Jun 21, 2024
  • 1y Target Est 688.00

Archean Chemical Industries Limited manufactures and sells specialty marine chemicals in India and internationally. It offers bromine for use in pharmaceuticals, agrochemicals, flame retardants, and water treatment products, as well as oil and gas, and energy storage industries; industrial salt for chloralkali chemical, food and beverage, water treatment, and oil and gas industries; and sulphate of potash, an inorganic salt for agrochemicals, medical, glass, cosmetics, etc. Industries. The company was founded in 2003 and is based in Chennai, India.

www.archeanchemicals.com

288

Full Time Employees

March 31

Fiscal Year Ends

Chemicals

Industry

Recent News: ACI.NS

View More

Performance Overview: ACI.NS

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

ACI.NS
18.32%
S&P BSE SENSEX (^BSESN)
2.36%

1-Year Return

ACI.NS
16.49%
S&P BSE SENSEX (^BSESN)
3.27%

3-Year Return

ACI.NS
21.53%
S&P BSE SENSEX (^BSESN)
28.71%

5-Year Return

ACI.NS
21.53%
S&P BSE SENSEX (^BSESN)
176.52%

Compare To: ACI.NS

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ACI.NS

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    66.23B

  • Enterprise Value

    62.92B

  • Trailing P/E

    40.02

  • Forward P/E

    18.25

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.97

  • Price/Book (mrq)

    3.77

  • Enterprise Value/Revenue

    6.60

  • Enterprise Value/EBITDA

    20.12

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    16.97%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    9.97%

  • Revenue (ttm)

    9.79B

  • Net Income Avi to Common (ttm)

    1.66B

  • Diluted EPS (ttm)

    13.46

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    4.64B

  • Total Debt/Equity (mrq)

    8.60%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ACI.NS

View More

Company Insights: ACI.NS

Research Reports: ACI.NS

View More

People Also Watch